HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Quote:
Login Free Membership
Search:

Press Releases  

Zacks Analyst Blog Highlights: Ciena Corp., Blyth Inc., Visa, Mead Johnson Nutrition Co. and Bristol-Myers Squibb Co.

Share
December 16, 2009 | Comment(s): 0
Recommended this article (6)
CIEN | BTH | V | MJN | BMY

For Immediate Release

Chicago, IL – December 16, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Ciena Corp. (CIEN - Analyst Report), Blyth Inc. (BTH - Snapshot Report), Visa (V - Analyst Report), Mead Johnson Nutrition Co. (MJN - Snapshot Report) and Bristol-Myers Squibb Co. (BMY - Analyst Report).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Tuesday’s Analyst Blog:

Ciena Out of S&P 500

According to Standard and Poor’s latest realignment, Ciena Corp. (CIEN - Analyst Report), the telecommunications equipment maker has been removed from the S&P 500 index and has been included in the S&P MidCap 400, replacing Blyth Inc. (BTH - Snapshot Report). Visa (V - Analyst Report) will replace Ciena in the S&P 500 Index.

After the announcement, Ciena shares fell 6.64%, as negative investor sentiments loomed on the stock. The S&P 500 Index includes companies with market capital of above $5 billion. Since Ciena has a market cap of $1 billion, it is no longer a representative of the market index and thus has been removed.

Standard & Poor's added five other companies to its S&P 500, including Mead Johnson Nutrition Co. (MJN - Snapshot Report), which is being split off from Bristol-Myers Squibb Co. (BMY - Analyst Report).

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com

 

 

Read the full analyst report on CIEN

Read the full analyst report on BTH

Read the full analyst report on V

Read the full analyst report on MJN

Read the full analyst report on BMY

 

Please login to Zacks.com or register to post a comment.


Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
Sell These Stocks Today
Make sure no Zacks #5 Rank "Strong Sell" stocks are lurking in your portfolio. They tend to perform only 1/6th as well as the market!
Get your free Welcome Gifts today*:
 1.  Zacks "Strong Sell" list.
 2.  Our e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 26, 2012 04:10 am ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center